KPJ Healthcare Berhad’s financial performance for the second quarter ended 30 June 2025 (Q2 FY2025) reflected continued growth in revenue and earnings, supported by higher patient volume, improved revenue intensity and expanded service capacity across the Group.
The Group recorded an 11% increase in revenue to RM1,024 million from RM925 million in the same quarter last year. This growth was supported by higher patient numbers, greater surgical volume and improved average revenue per inpatient case, reflecting increased clinical complexity and stronger case mix.
Profit before tax rose 10% to RM131 million, while EBITDA increased 9% to RM250 million. These results reflect the Group’s sustained operational focus, higher case volumes and improved efficiency in care delivery, even with an expanded capacity base.
PATAMI increased 8% to RM82 million. This was driven by strong revenue growth and prudent cost management, with PATAMI margin maintained at a healthy 8%.
For the quarter, inpatient admissions grew 2% to 92,665, while outpatient visits increased 4% to 703,802. Bed occupancy rate stood at 62%.
The Group declared an interim dividend of 1.05 sen per share, amounting to RM45.8 million, payable on 10 October 2025.
Chin Keat Chyuan, President and Managing Director of KPJ Healthcare said, “We are pleased to share that KPJ Healthcare achieved commendable results for second quarter revenue, made possible by the trust and support of our patients, physicians, partners and people - for which I am deeply grateful.
Net profit for the quarter rose by 40% compared to preceding quarter, reflecting a stronger performance. Gross profit margin stood at 44.1% for the quarter and 43.6% for the six months period ended 2025, reflecting prudent financial management. Our revenue increased 11% compared to Quarter 2 2024 and 9% for the six months period ended 2025, achieved through stronger demand and improved case mix across our hospitals.
Through our transformation plan and portfolio restructuring which started in 2023, we have successfully exited Bangladesh and reinforced Malaysia as our core focus and key growth driver. The Ministry of Health’s recent decision to defer DRG implementation to 2027 provides clarity for stakeholders and allows time to strengthen system readiness in a more sustainable manner.
Under the KPJ Health System, we are strengthening subspecialty services, expanding our digital capabilities and laying the foundation for future Centres of Excellence. This is not just about growth - it is about raising the quality of our “Care for Life” services so that our patients and communities can trust us today and into the future. Our focus is simple, to deliver care that is accessible, sustainable and truly centred on the people we serve as we continue to heal, teach and discover for all.”
KPJ Healthcare remains cautiously optimistic about its prospects for the financial year 2025, supported by sustained patient demand and its ongoing efforts to improve operational efficiency. These include asset optimisation, capacity expansion and disciplined cost management.
Bank Negara Malaysia has projected GDP growth between 4.0% and 4.8% for 2025. The Ministry of Health’s decision to defer the implementation of the Diagnosis Related Group (DRG) system to 2027 also provides added clarity for a smoother, more sustainable transition.
This content is provided by KPJ Healthcare
The views expressed here are those of the author/contributor and do not necessarily represent the views of Malaysiakini.
Interested in having your press releases, exclusive interviews, or branded content articles on Malaysiakini? For more information, contact [email protected] or [email protected]
